What You Should Know:
PathAI Diagnostics, formerly Poplar Healthcare, a leading laboratory services company, today unveiled the world’s first AI-assisted laboratory-developed test for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).MASLD and…
Continue Reading
A long and deeply-reported feature story in The Washington Post on Tuesday put a spotlight on the stark effect that an epidemic of chronic illness is taking on too many millions of Americans.”Forty years…
Continue Reading
Owlstone Medical has presented new data showing the progress being made in the development of breath biopsy tests for liver cirrhosis and non-alcoholic steatohepatitis (NASH) at the EASL Congress 2023. Dynamic Limonene Breath Testing…
Continue Reading
Somerset NHS Foundation Trust, Sano Genetics and Predictive Health Intelligence have secured £800k from an Innovate UK funding competition to develop and test a system that can identify high-risk liver disease cases.The trio’s aim…
Continue Reading
